5-hydroxymethyluracil has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abakir, A; Gackowski, D; Gawronski, M; Kerr, C; Maciejewski, JP; Olinski, R; Radivoyevitch, T; Ruzov, A; Starczak, M; Zarakowska, E | 1 |
1 other study(ies) available for 5-hydroxymethyluracil and Myelodysplastic Syndromes
| Article | Year |
|---|---|
5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.
Topics: Biomarkers; Cytosine; Dioxygenases; DNA-Binding Proteins; Humans; Mutation; Myelodysplastic Syndromes; Pentoxyl; Phosphoproteins; Proto-Oncogene Proteins; RNA Splicing Factors | 2020 |